Rohini Kuner

Rohini Kuner serves as Professor and Chair of the Department of Molecular Pharmacology at Heidelberg University's Medical Faculty, Germany, a position held since 2006 with prior directorship of the Institute of Pharmacology (2009-2012). Her academic journey spans international institutions including University of Iowa (PhD) and Max-Planck Institute.

Education:

• 1987-1991: Pharmaceutical Technology, University of Bombay
• 1994: PhD in Pharmacology, University of Iowa (Supervisor: Prof. G.F. Gebhart)
• 2005: Habilitation in Pharmacology and Toxicology, Heidelberg University

Research Focus: Professor Kuner's work pioneers molecular mechanisms of chronic pain, investigating nervous system plasticity in neurological disorders through neuropharmacological approaches. Her laboratory identifies critical pathways involving calcium signaling, synaptic scaffolding proteins, and tumor-nerve interactions that drive persistent pain states.

Publication Trends: Recent works (2013-2009) reveal consistent exploration of inflammatory and cancer pain mechanisms, with emphasis on genomic regulation in spinal neurons, hematopoietic factors in bone pain, and receptor subunit dynamics. These studies bridge molecular discoveries with clinical pain management applications.

Scientific Recognition:

• ERC Advanced Investigator Grant (2011)
• Pat Wall International Young Investigator Award (2010)
• National Basic Pain Research Award (2007)
• Rudolf-Buchheim Prize (2005)
• Multiple early-career awards (2006-2008)

Leadership & Service: As Coordinator of Research Area C in the Excellence Cluster 'CellNetworks', she directs interdisciplinary neuroscience initiatives. Her editorial leadership includes Section Editor for 'Pain' and Associate Editor for 'European Journal of Neuroscience', alongside service on DFG research panels and ERC grant committees.